Quality of life more than 10 years after radiotherapy for localized prostate cancer-impact of time after treatment and prescription dose

被引:6
作者
Pinkawa, Michael [1 ,2 ]
Gharib, Amr [1 ]
Schlenter, Marsha [1 ]
Timm, Ludmila [1 ,2 ]
Eble, Michael J. [1 ]
机构
[1] Rhein Westfal TH Aachen, Dept Radiat Oncol, Pauwelsstr 30, D-52072 Aachen, Germany
[2] MediClin Robert Janker Klin, Dept Radiat Oncol, Villenstr 8, D-53129 Bonn, Germany
关键词
Prostate neoplasms; Conformal radiotherapy; Quality of life; Dose-response relationship; RATE BRACHYTHERAPY; THERAPY; RISK; MEN;
D O I
10.1007/s11136-020-02639-7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose Analysis of quality of life changes after radiotherapy with focus on the impact of time after treatment and prescription dose. Methods Consecutive patients were treated with doses from 70.2/1.8 Gy (n = 206) to 72/1.8-2.0 Gy (n = 176) in a single centre and surveyed using the Expanded Prostate Cancer Index Composite questionnaire. Results Urinary and bowel bother scores decreased 1 / 3 / 6 points and 7 / 7 / 9 points on average 1 / 5 / 10 years after RT in comparison to baseline scores. The rate of urinary (need of pads in 8% vs. 15% before vs. 10 years after RT; p = 0.01) and bowel (uncontrolled leakage of stool in 5% vs. 12% before vs. 10 years after RT; p < 0.01) incontinence, as well as rectal bleeding (4% vs. 8% before vs. 10 years after RT; p = 0.05) increased. Sexual function scores decreased (erections sufficient for intercourse in 36% vs. 12% before vs. 10 years after RT; p < 0.01). A higher dose had a statistically significant impact on urinary bother and stool incontinence, but also tended to decrease urinary continence. Age and comorbidities did not have an influence on score changes, but on baseline urinary function/bother and baseline sexual function. Conclusion Apart from an increasing rate of erectile dysfunction, urinary and bowel incontinence rates increased with increasing follow-up period. A higher dose was found to be associated with increased urinary problems and larger stool incontinence rates. Age and comorbidities were found to be relevant for baseline scores, but not for score changes.
引用
收藏
页码:437 / 443
页数:7
相关论文
共 20 条
  • [1] Improving rectal dosimetry for patients with intermediate and high-risk prostate cancer undergoing combined high-dose-rate brachytherapy and external beam radiotherapy with hydrogel space
    Chao, Michael
    Ow, Darren
    Ho, Huong
    Chan, Yee
    Joon, Daryl Lim
    Spencer, Sandra
    Lawrentschuk, Nathan
    Guerrieri, Mario
    Pham, Trung
    McMillan, Kevin
    Tan, Alwin
    Foroudi, Farshad
    Tang, Johann
    Wasiak, Jason
    Liu, Madalena
    Koufogiannis, George
    Cham, Chee Wee
    Bolton, Damien
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2019, 11 (01) : 8 - 13
  • [2] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [3] The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
    Epstein, JI
    Allsbrook, WC
    Amin, MB
    Egevad, LL
    Bastacky, S
    Beltrán, AL
    Berner, A
    Billis, A
    Boccon-Gibod, L
    Cheng, L
    Civantos, F
    Cohen, C
    Cohen, MB
    Datta, M
    Davis, C
    Delahunt, B
    Delprado, W
    Eble, JN
    Foster, CS
    Furusato, M
    Gaudin, PB
    Grignon, DJ
    Humphrey, PA
    Iczkowski, KA
    Jones, EC
    Lucia, S
    McCue, PA
    Nazeer, T
    Oliva, E
    Pan, CC
    Pizov, G
    Reuter, V
    Samaratunga, H
    Sebo, T
    Sesterhenn, I
    Shevchuk, M
    Srigley, JR
    Suzigan, S
    Takahashi, H
    Tamboli, P
    Tan, PH
    Têtu, B
    Tickoo, S
    Tomaszewski, JE
    Troncoso, P
    Tsuzuki, T
    True, LD
    van der Kwast, T
    Wheeler, TM
    Wojno, KJ
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (09) : 1228 - 1242
  • [4] Fowler JF, 2013, ANTICANCER RES, V33, P1009
  • [5] ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer
    Ghadjar, Pirus
    Fiorino, Claudio
    af Rosenschold, Per Munck
    Pinkawa, Michael
    Zilli, Thomas
    van Der Heide, Uulke A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 141 : 5 - 13
  • [6] Impact of age on quality of life in patients with localized prostate cancer treated with high-dose rate brachytherapy combined with external beam radiotherapy
    Kikkawa, Kazuro
    Iba, Akinori
    Kohjimoto, Yasuo
    Noda, Yasutaka
    Sonomura, Tetsuo
    Hara, Isao
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (04) : 366 - 371
  • [7] LONG-TERM FAILURE PATTERNS AND SURVIVAL IN A RANDOMIZED DOSE-ESCALATION TRIAL FOR PROSTATE CANCER. WHO DIES OF DISEASE?
    Kuban, Deborah A.
    Levy, Lawrence B.
    Cheung, M. Rex
    Lee, Andrew K.
    Choi, Seungtaek
    Frank, Steven
    Pollack, Alan
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05): : 1310 - 1317
  • [8] Quality of Life Changes &gt;10 Years After Postoperative Radiation Therapy After Radical Prostatectomy for Prostate Cancer
    Leufgens, Friederike
    Berneking, Vanessa
    Voegeli, Thomas-Alexander
    Kirschner-Hermanns, Ruth
    Eble, Michael J.
    Pinkawa, Michael
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (02): : 382 - 388
  • [9] Association of the Placement of a Perirectal Hydrogel Spacer With the Clinical Outcomes of Men Receiving Radiotherapy for Prostate Cancer A Systematic Review and Meta-analysis
    Miller, Larry E.
    Efstathiou, Jason A.
    Bhattacharyya, Samir K.
    Payne, Heather A.
    Woodward, Emily
    Pinkawa, Michael
    [J]. JAMA NETWORK OPEN, 2020, 3 (06)
  • [10] Ozyigit G, 2019, STRAHLENTHER ONKOL, V195, P882, DOI 10.1007/s00066-019-01476-z